Wnt/Ca2+/NFAT signaling maintains survival of Ph+ leukemia cells upon inhibition of Bcr-Abl.
about
ABL tyrosine kinases: evolution of function, regulation, and specificityChemotherapeutic agents circumvent emergence of dasatinib-resistant BCR-ABL kinase mutations in a precise mouse model of Philadelphia chromosome-positive acute lymphoblastic leukemiaAberrant Wnt Signaling in LeukemiaNarrowing the focus: a toolkit to systematically connect oncogenic signaling pathways with cancer phenotypesNuclear factor of activated T cells (NFAT) proteins repress canonical Wnt signaling via its interaction with Dishevelled (Dvl) protein and participate in regulating neural progenitor cell proliferation and differentiationThe p53 circuit boardKnockout Serum Replacement Promotes Cell Survival by Preventing BIM from Inducing Mitochondrial Cytochrome C ReleaseABL fusion oncogene transformation and inhibitor sensitivity are mediated by the cellular regulator RIN1.Tumor suppressor DYRK1A effects on proliferation and chemoresistance of AML cells by downregulating c-Myc.Growth of tyrosine kinase inhibitor-resistant Philadelphia-positive acute lymphoblastic leukemia: Role of bone marrow stromal cellsInhibition of calcineurin combined with dasatinib has direct and indirect anti-leukemia effects against BCR-ABL1(+) leukemia.Pooled shRNA screen for sensitizers to inhibition of the mitotic regulator polo-like kinase (PLK1).Wnt/β-catenin pathway regulates ABCB1 transcription in chronic myeloid leukemia.Using functional genomics to overcome therapeutic resistance in hematological malignancies.Sphingosine kinase-1 and sphingosine 1-phosphate receptor 2 mediate Bcr-Abl1 stability and drug resistance by modulation of protein phosphatase 2A.Tyrosine kinase inhibition in leukemia induces an altered metabolic state sensitive to mitochondrial perturbations.Galectin-3 (Gal-3) induced by leukemia microenvironment promotes drug resistance and bone marrow lodgment in chronic myelogenous leukemiaMolecular perturbations restrict potential for liver repopulation of hepatocytes isolated from non-heart-beating donor rats.Noncanonical Wnt signaling maintains hematopoietic stem cells in the niche.Role in tumor growth of a glycogen debranching enzyme lost in glycogen storage disease.Vav3 collaborates with p190-BCR-ABL in lymphoid progenitor leukemogenesis, proliferation, and survival.NFAT as cancer target: mission possible?Study of Arsenic Sulfide in Solid Tumor Cells Reveals Regulation of Nuclear Factors of Activated T-cells by PML and p53.Antitumor activity of a potent MEK inhibitor, TAK-733, against colorectal cancer cell lines and patient derived xenografts.WNT5A-NFAT signaling mediates resistance to apoptosis in pancreatic cancerFirst-line treatment of chronic myeloid leukaemia.Targeting developmental pathways in children with cancer: what price success?Tankyrase and the canonical Wnt pathway protect lung cancer cells from EGFR inhibition.NFAT5 represses canonical Wnt signaling via inhibition of β-catenin acetylation and participates in regulating intestinal cell differentiation.PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells.CXXC5 (retinoid-inducible nuclear factor, RINF) is a potential therapeutic target in high-risk human acute myeloid leukemiaKch1 family proteins mediate essential responses to endoplasmic reticulum stresses in the yeasts Saccharomyces cerevisiae and Candida albicans.ATM/G6PD-driven redox metabolism promotes FLT3 inhibitor resistance in acute myeloid leukemia.Phospho-sulindac inhibits pancreatic cancer growth: NFATc1 as a drug resistance candidateCML cells actively evade host immune surveillance through cytokine-mediated downregulation of MHC-II expression.Chronic myeloid leukemia stem cells and developing therapies.Development of an effective therapy for chronic myelogenous leukemiaNFAT gene family in inflammation and cancer.While at Rome miRNA and TRAIL do whatever BCR-ABL commands to do.Wnt signaling in normal and malignant hematopoiesis.
P2860
Q24299738-5E4146E9-7C0A-470C-953E-0B522514921FQ24622397-1603E564-9C18-4177-8384-58DF0F76D32CQ26738411-8DA0742E-978C-4E0B-805D-D08BCAA072AEQ28072745-FA629A47-7B2A-437D-99A9-849463D08B53Q28116474-74ED9822-5FB6-4D8C-9990-FE2AD112B64FQ28259725-49C44BC2-A2CE-4C60-B312-F84C68288DBCQ28550350-8B574DC3-4671-4635-8C7F-05D25EADD81AQ30155948-D8B3EA29-350E-4A6E-A238-656791EA8BD1Q31164546-9E9D099B-A779-4354-BA52-DA79F3D039A6Q33597756-9277A0C1-6206-461B-B6F0-B2E5996D3022Q34052899-F1B69B88-4585-44FF-B86C-CF1727BA2949Q34128812-FDA065F5-6AD2-4CF2-A13C-B3731D599343Q34348134-1EE44DB5-6E27-43CA-B93F-46C90EACFC8CQ34401328-E91406D2-CA3B-44F7-9C35-416D0D5BC104Q35037415-76A2ABC5-C689-4FD6-8ABD-02585D4E4D11Q35178420-20215478-7E70-4F98-A6A1-E8663A8AB4E4Q35409569-6D7109B7-3E63-44BC-9392-661FC32B43C6Q35736774-846D216F-306B-4FAE-8112-60E3A50423A3Q35821670-F59AA243-A7D7-4B6E-B9ED-36CE7455441AQ36087194-CC7458C2-1798-41D9-9C6B-A78D8915ED14Q36141909-76B70FEC-BC6C-4E7E-888E-BB7958A3BA29Q36455193-0C7D667E-FD0F-4EA1-AE0A-04885011C627Q36500275-FEF35040-E0D3-424A-860B-1FBC95678E4DQ36544152-077A030D-DA66-4FBB-AED0-5EEC5E95DC30Q36567558-188B3818-829C-4811-9EC9-A1B9E1248194Q36612527-03862801-94D8-4ACE-B061-6387B229F122Q36905620-EDEBE5D8-9079-427A-A2A0-155DC963E50BQ36905632-6AE86423-B8D9-4E93-A551-B632444A1FBDQ36985073-D68F60C2-8CB3-4EA7-9E20-3A9ED7628185Q37200863-60530E6A-BE28-4D2A-A49F-2826C0760864Q37299309-A7B9BA7F-054C-4090-B579-FDE7A4EC09E3Q37349001-A88D9049-58FC-454E-B584-55A63A7098C2Q37379680-8BF4DBB9-7FD9-43F9-A9DB-945DB4835BACQ37504288-36BCEBCF-C51B-420F-9418-A6898D45EEF6Q37638846-FC8A915C-63BB-4B9D-9620-8998D6D72E27Q37836936-D2729683-365A-4E70-96C0-ED88F5D8CF6CQ37966917-D318B142-B657-4EC5-9BD6-482B4801191FQ38040813-9C02E62D-D1B9-4B12-ABE4-BFF78F0A767FQ38066406-EE917733-4534-4E9C-9591-BAB0B90CDE6DQ38078915-B8C477F8-4C69-44D4-94F5-6094E523B1D7
P2860
Wnt/Ca2+/NFAT signaling maintains survival of Ph+ leukemia cells upon inhibition of Bcr-Abl.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Wnt/Ca2+/NFAT signaling mainta ...... ls upon inhibition of Bcr-Abl.
@ast
Wnt/Ca2+/NFAT signaling mainta ...... ls upon inhibition of Bcr-Abl.
@en
type
label
Wnt/Ca2+/NFAT signaling mainta ...... ls upon inhibition of Bcr-Abl.
@ast
Wnt/Ca2+/NFAT signaling mainta ...... ls upon inhibition of Bcr-Abl.
@en
prefLabel
Wnt/Ca2+/NFAT signaling mainta ...... ls upon inhibition of Bcr-Abl.
@ast
Wnt/Ca2+/NFAT signaling mainta ...... ls upon inhibition of Bcr-Abl.
@en
P2093
P2860
P1433
P1476
Wnt/Ca2+/NFAT signaling mainta ...... lls upon inhibition of Bcr-Abl
@en
P2093
Christopher A Eide
Danilo Perrotti
Francesca Alvarez-Calderon
Mark A Gregory
Paolo Neviani
Richard T Williams
Thomas O'Hare
Tzu L Phang
Vadym Zaberezhnyy
P2860
P356
10.1016/J.CCR.2010.04.025
P577
2010-07-01T00:00:00Z